Pandemic H1N1 influenza with atypical presentation: Encephalopathy and severe thrombocytopenia

[tetano]

Indian J Crit Care Med. 2012 Jan;16(1):60-1.
Pandemic H1N1 influenza with atypical presentation: Encephalopathy and severe thrombocytopenia.
Gurjar M, Kothari N, Baronia AK.
Source

Department of Critical Care Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

PMID:
22557839
[PubMed - in process]
PMCID:
PMC3338245

http://www.ncbi.nlm.nih.gov/pubmed/22557839

[Emily]

Re: Pandemic H1N1 influenza with atypical presentation: Encephalopathy and severe thrombocytopenia

http://www.ijccm.org/article.asp?issn=0972-5229;year=2012;volume=16;issue=1;spage=60;epage=61;aulast=Gurjar

How to cite this article:
Gurjar M, Kothari N, Baronia A K. Pandemic H1N1 influenza with atypical presentation: Encephalopathy and severe thrombocytopenia. Indian J Crit Care Med 2012;16:60-1
<table class="sitethis" border="0" width="100%"> <tbody><tr><td class="other">How to cite this URL:
Gurjar M, Kothari N, Baronia A K. Pandemic H1N1 influenza with atypical presentation: Encephalopathy and severe thrombocytopenia. Indian J Crit Care Med [serial online] 2012 [cited 2013 Aug 23];16:60-1. Available from: http://www.ijccm.org/text.asp?2012/16/1/60/94445</td></tr></tbody></table>

Sir,

A 43-year-old male, employee in an office of a teaching hospital, presented in the emergency room (ER) with history of high-grade fever and body ache for 10 days and altered sensorium for 1 day. For the current illness, he was treated with analgesic and antipyretic on an outpatient basis during his previous visits. On examination in ER, his GCS E3V3M4, heart rates 110/m, blood pressure 138/80 mmHg, respiratory rate 16-18/m, temperature 38.8?C, peripheral edema, urine output 50-60 mL/h and signs for meningitis were absent. At the time of admission, his arterial blood gas analysis on venturi mask (0.4 FiO ₂ ) showed pH 7.38, paO ₂ 86 mmHg, paCO ₂ 35.9 mmHg, HCO3 ^- 21.9 mmol/L, BD -2.8, Na ⁺ 142 mEq/L, K ⁺ 3.4 mEq/L, Cl ^- 103 mEq/L and lactates 1.8 mmol/L. Because of worsening of sensorium and unable to protect his airway, endotracheal intubation was done and he was kept on mechanical ventilation and shifted to the intensive care unit for further care. Empirically, ceftriaxone i.v. was started along with other supportive care. Routine laboratory investigations revealed Hb 11.6 g/dL, Hct 35.3%, TLC 12300 cells/μL, platelets 28000 cells/μL, S. creatinine 1.7 mg/dL, S. bilirubin 5.3 mg/dL (total), 4.2 mg/dL (direct), AST/ALT 264/107, alk phosphtase 915, PT 13.5 s (11.5 s), aPTT 44.1 s (c: 26.8 s) and INR 1.16, CPK 66 U/L, LDH 1200 U/L. Peripheral blood smear was negative for hemolysis. Chest X-ray findings were within normal limits. Magnetic resonance imaging head revealed normal study. Cerebrospinal fluid (CSF) study could not be done due to thrombocytopenia.

In further diagnostic work-up, dengue (IgM ELISA), malaria (blood peripheral smear for parasite and malarial antigen) and serology for other infective agents (HBsAg, HAV, HEV, HIV and IgM ELISA for Leptospira) were ruled out. Meanwhile, due to the ongoing epidemic of H1N1 influenza, endotracheal aspirate were sent for possible H1N1 infection and samples was found positive for H1N1 influenza viral infection by the reverse transcription polymerase chain reaction (RT-PCR) method (Applied Biosystem ^TM ). Oseltamivir at a dose of 75 mg twice daily was added in his treatment on the third day of ICU admission. His fever settled out, sensorium and thrombocytopenia also showed improvement by fifth day of ICU admission [Table 1]. No platelet transfusion was required and it was observed that after starting oseltamivir the platelet count improved from 30 to 360 x 10 ³ cells/μL. The patient was weaned from the ventilator and extubated. He showed speedy recovery after receiving oseltamivir and was discharged from the ICU in the next 5 days. His total duration of ICU stay was10 days.<table cellpadding="1" cellspacing="1" width="100%"><tbody><tr><td align="center" bgcolor="#f3f3f3" width="200px"></td><td style="padding:5px;" bgcolor="#eaeaea">Table 1: Clinical course of patient during ICU stay

Click here to view</td></tr></tbody></table>

Infection due to H1N1 influenza is commonly presented with flu-like symptoms, while in the severe form this may manifest as pneumonia and respiratory failure. Recently, few cases of atypical presentation like encephalopathy due to H1N1 have been reported worldwide, mainly in childhood, including extensive cortical-subcortical necrosis with high morbidity and mortality. ^{[1],[2],[3],[4]} From India also, there is a case report of encephalitis-like findings in a patient of H1N1 influenza.* ^[5] The underlying mechanism of encephalopathy in H1N1 infection still remains unclear, with multiple theories including host immune response and genetic susceptibility, and CSF findings are usually not helpful in the diagnosis. ^[4],[6],[7] Our case had late-onset (second week) encephalopathy as opposed to early-onset (within 48 h) encephalopathy found in patients with influenza A and B, which may reflect different mechanism of pathogenesis. ^[8] Also, in pandemic H1N1 influenza, frequent abnormal laboratory parameters are high lactate dehydrogenase, creatine kinase, aminotransferases and white blood cells. ^[5],[9] Although thrombocytopenia is not uncommon and may be present in up to 20% of the hospitalized patients with H1N1 influenza, severe thrombocytopenia is very infrequent. ^[5],[9] Our case had atypical presentation of H1N1 influenza with encephalopathy and severe thrombocytopenia. Because of such variable presentations of H1N1 virus, patients with viral fever, with or without flu-like symptoms, should be suspected and screened for H1N1 virus infection, especially in the presence of thrombocytopenia that could mimic dengue fever.

<table class="leftNav" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="pageSub" height="15px"> ? References</td><td class="inthis" align="right" height="15px">
</td><td align="right" height="15px" width="15%"></td></tr></tbody></table>
<table class="body" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td valign="top" width="5%">1.</td><td>Chen YC, Lo CP, Chang TP. Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features--a case report. J Neurol Sci 2010;298:110-3.
</td></tr> <tr><td valign="top" width="5%">2.</td><td>Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol 2010;40:200-5.
</td></tr> <tr><td valign="top" width="5%">3.</td><td>Webster RI, Hazleton B, Suleiman J, Macartney K, Kesson A, Dale RC. Severe encephalopathy with swine original influenza A H1N1 infection in childhood: case reports. Neurology 2010;74:1077-8.
</td></tr> <tr><td valign="top" width="5%">4.</td><td>Akins PT, Belko J, Uyeki TM, Axelrod Y, Lee KK, Silverthorn J. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care 2010;13:396-406.
</td></tr> <tr><td valign="top" width="5%">5.</td><td>Chacko J, Gagan B, Ashok E, Radha M, Hemanth HV. Critically ill patients with 2009 H1N1 infection in an Indian ICU. Indian J Crit Care Med 2010;14:77-82.
[PUBMED] </td></tr> <tr><td valign="top" width="5%">6.</td><td>Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol 2010;23:305-11.
</td></tr> <tr><td valign="top" width="5%">7.</td><td>Sejvar JJ, Uyeki TM. Neurologic complications of 2009 influenza A (H1N1): heightened attention on an ongoing question. Neurology 2010;74:1020-1.
</td></tr> <tr><td valign="top" width="5%">8.</td><td>Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002;35:512-7.
</td></tr> <tr><td valign="top" width="5%">9.</td><td>Ugarte S, Arancibia F, Soto R. Influenza A pandemics: clinical and organizational aspects: the experience in Chile. Crit Care Med 2010;38(4 Suppl):e133-7.
</td></tr> </tbody></table>

<table class="leftNav" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="pageSub"> Tables</td></tr></tbody></table>
[Table 1]

Published by Medknow <table style="border-collapse:collapse" cellpadding="0" cellspacing="0"><tbody><tr><td height="5">
</td></tr><tr><td> </td></tr></tbody></table>ISSN: Print -0972-5229, Online - 1998-359X

<ins style="display:inline-table;border:none;height:90px;margin:0;padding:0;p osition:relative;visibility:visible;width:728px"></ins>